Silo Pharma, Inc.
Price Action
Technical Summary
CONSOLIDATINGSilo Pharma, Inc. is in a consolidation phase, trading with mixed signals as moving averages converge. Relative strength is moderate (RS Rating: 57), indicating performance broadly in line with the market. Earnings growth of 45% provides fundamental context to the price action. Investors should exercise caution due to high volatility (120% annualized), which requires wider risk management.
Trend Template (Minervini)
Price vs Moving Averages
| Period | Value | Spread | Signal |
|---|---|---|---|
| 20 SMA | $0.48 | -11.42% | BELOW |
| 50 SMA | $0.41 | +3.69% | ABOVE |
| 100 SMA | $0.38 | +10.99% | ABOVE |
| 150 SMA | $0.43 | -1.36% | BELOW |
| 200 SMA | $0.49 | -14.20% | BELOW |
Price Performance
Technical Indicators
Risk Profile
Volume Analysis
Earnings Momentum
Growth Trends
Compounded Sales Growth
Compounded Profit Growth
Stock Price CAGR
Return on Equity
Key Metrics
Frequently Asked Questions
Is SILO in an uptrend right now?
SILO has a trend score of 2/4 based on Minervini's Stage Analysis. Currently showing partial alignment - 2 of 4 trend criteria are met.
Is SILO overbought or oversold?
SILO's RSI (14) is 50. The stock is in neutral territory, neither overbought nor oversold.
Is SILO outperforming the market?
SILO has a Relative Strength (RS) Rating of 57 out of 99. SILO is performing about average compared to the market.
Where is SILO in its 52-week range?
SILO is trading at $0.42, which is 37% of its 52-week high ($1.13) and 22% above its 52-week low ($0.22).
How volatile is SILO?
SILO has a Beta of 2.21 and 52-week volatility of 120%. It's more volatile than the S&P 500 - expect bigger swings.